MRK Trading Analysis - 10/23/2026 02:05 PM — TRU-SENTIMENT

MRK (Merck & Co. Inc.) at $147.35. True Sentiment Balanced, delta 40-60 call 45% / put 55%, call $881,445 vs put $1,079,823. RSI 56.5.

TRU-SENTIMENT · DeltaNeutral

MRK Trading Analysis - 10/23/2026 02:05 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

MRK (Merck & Co. Inc.) at $147.35. True Sentiment Balanced, delta 40-60 call 45% / put 55%, call $881,445 vs put $1,079,823. RSI 56.5.

Symbol
MRK
Price
$147.35
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-10-23 14:05:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From the True Sentiment options file (Delta 40-60 only):

Call Dollar Volume: $881,445 (44.9%) Put Dollar Volume: $1,079,823 (55.1%) Total: $1,961,268

  • Sentiment labeled "Balanced" with put notional edge of ~$198K.
  • Call contracts 1,683 vs put 1,955; call trades 35 vs put 32 — similar trade count, more put contracts.
  • Filter ratio 5.1% (67 of 1,314 options analyzed) shows limited pure directional conviction.
  • Read: near-term expectations are non-directional; no strong bullish or bearish flow confirmation.
Note: Options flow is the only sentiment source; no live X posts were retrieved for this run.

Key Statistics: MRK

$148.27 +0.00%
52-Week Range
$82.01 - $156.92
Market Cap
$365.81B
P/E (TTM)
116.80
PEG Ratio
N/A
Beta
-0.02
Next Earnings
N/A
Avg Volume
$6.60M
Dividend Yield
0.02%

Fundamental Snapshot

Valuation

P/E (trailing)116.80
EPS (trailing 12 mo)$1.27
Market cap$365.81B
Shares outstanding2,467.2M

Dividend

Dividend yield2.29%
Annual dividend$3.40
Ex-dividend date2026-09-15

Risk & range

Beta-0.02
52-week low$82.01
52-week high$156.92
Historical volatility26.4%

Ownership & trading

Institutional ownership55.2%
Average daily volume9.2M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

Recent general-knowledge headlines and context for Merck & Co (MRK) that may frame the current trading environment:

  • MRK recently completed ex-dividend date on 2026-09-15 with a declared dividend rate of $3.40 (yield 2.29%), a routine shareholder event with no major surprise.
  • Pipeline headlines around Keytruda expansion and HPV vaccine demand have circulated in prior quarters; no blockbuster catalyst confirmed in provided data.
  • Broad pharma sector has faced pricing-policy and patent-cliff discussions, which can introduce headline volatility for large caps like MRK.
  • No earnings date is embedded in the data; fiscal year end is listed as 2025-12-01, suggesting next full-year reporting is not imminent in the window shown.
  • Context: The news backdrop is calm relative to the sharp 2026-10-22 intraday range ($144.07–$154.02), where price reversed hard off highs into the close.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS data for MRK:

  • Trailing P/E is 116.80 with trailing EPS of $1.27 — a rich multiple versus typical large-cap pharma peers in the mid-teens to low-30s P/E.
  • PEG ratio, forward P/E, forward EPS, profit margins, ROE, debt/equity, and free cash flow are all null — unavailable in the data, preventing margin-quality assessment.
  • Market cap is $365.81B with 2.47B shares outstanding; institutional ownership is 55.21%.
  • Dividend yield 2.29% (rate $3.40) provides income context but no growth signal in the data.
  • Beta is -0.02, indicating historically low/negative correlation to broad market moves in the dataset.
  • 52-week range: $82.01 low to $156.92 high; current price $148.27 sits in the upper-middle of that range.
  • Analyst consensus and target mean price are null — no street target context provided.
  • Fundamentals show a high valuation with missing margin data, which diverges from the neutral-to-mildly-positive technical picture and balanced options sentiment.

Current Market Position

Current price per indicators is $148.27 (2026-10-22 close). Recent daily action shows a gap-up open at $151.05 on 2026-10-22, a session high of $154.02, then a collapse to low $144.07 and close $148.27 on volume of 15.63M (well above 20-day avg of 5.90M).

Minute bars for 2026-10-21 to 2026-10-22 show opening strength to ~$149.84 on 10-21, then on 10-22 a fade from $149.49 at 15:35 to $147.35 by 15:55 with volume spikes to 543,130 in the final bar — clear late-session distribution.

Support
$144.07
Resistance
$154.02
20-day SMA
$145.47
50-day SMA
$146.50
30-day Low
$138.80

Technical Analysis

Technical Indicators

Current Price
$148.27
SMA 5
$147.23
SMA 20
$145.47
SMA 50
$146.50
RSI 14
56.52
MACD
0.81 / 0.64
BB Upper
$151.26
BB Lower
$139.69
ATR 14
$4.38
  • Price $148.27 is above SMA 5 ($147.23), SMA 20 ($145.47), and SMA 50 ($146.50) — short-term alignment is mildly bullish but compressed.
  • RSI 14 at 56.52 shows neutral-to-soft momentum, no overbought condition.
  • MACD line 0.81 > signal 0.64, histogram +0.16 — mild positive momentum, no bearish divergence in data.
  • Bollinger middle $145.47, upper $151.26, lower $139.69; price inside upper half, not at band extreme.
  • 30-day range high $154.02, low $138.80; price at $148.27 is ~64% up the range.

True Sentiment Analysis (Delta 40-60 Options)

From the True Sentiment options file (Delta 40-60 only):

Call Dollar Volume: $881,445 (44.9%) Put Dollar Volume: $1,079,823 (55.1%) Total: $1,961,268

  • Sentiment labeled "Balanced" with put notional edge of ~$198K.
  • Call contracts 1,683 vs put 1,955; call trades 35 vs put 32 — similar trade count, more put contracts.
  • Filter ratio 5.1% (67 of 1,314 options analyzed) shows limited pure directional conviction.
  • Read: near-term expectations are non-directional; no strong bullish or bearish flow confirmation.
Note: Options flow is the only sentiment source; no live X posts were retrieved for this run.

Key Price Levels (Observational Only)

Support (10-22 Low)
$144.07
Resistance (10-22 High)
$154.02
Bollinger Mid
$145.47
Bollinger Upper
$151.26
30-day Low
$138.80

Interactive charts load with JavaScript. This text is the crawlable summary.